COVID-19 and Challenges in Advanced Heart and Lung Disease and Cardiothoracic Transplantation

Wednesday, April 29, 2020 4:00 – 5:30 PM EDT


 
Our first ISHLTv event explored the aspects of care surrounding our patients, including clinical presentation, current epidemiology, therapeutic options, critical care, support devices and donor management. First-hand experiences from the frontlines of the pandemic will be presented.
 
 
 
Session Summary: The rapid spread of COVID-19, caused by the SARS-CoV-2 coronavirus, has affected all aspects of medical care, including advanced heart and lung disease and cardiothoracic transplantation. Clinical presentation, current epidemiology, therapeutic options, critical care, support devices and donor management will be included among the aspects of patient care explored in this session. Additionally, first-hand experiences from the frontlines of the pandemic will be presented.

Moderators: Saima Aslam, MD, MS and Lara Danziger-Isakov, MD, MPH

Welcome
Stephan Ensminger, MD, Phil, University of Lubeck, Lubeck, Germany

President's Message
Stuart Sweet, MD, PhD, St. Louis Children's Hospital, St. Louis, MO, USA

Pathogenesis, Clinical Presentation, Epidemiology in Transplantation
Erika D. Lease, MD, FCCP, University of Washington, Seattle, WA, USA
The common pathogenesis, clinical presentation and current knowledge of epidemiology in cardiothoracic transplantation will be discussed.

Therapeutic Options
Michael Shullo, PharmD, WVU Medicine, Morgantown, WV, USA
Therapeutic options for treating COVID-19 and the inflammatory response to infection that are specific to cardiothoracic transplantation and pulmonary vascular disease including drug-drug interactions and emerging therapeutics will be discussed.

Critical Care in COVID-19
Marta Farrero Torres, MD, PhD, Hospital Clinic de Barcelona, Barcelona, Spain
Critical care remains the backbone for supporting critically ill patients. Challenges and techniques specific to COVID-19 will be addressed.

MCS/ECMO in COVID-19
Daniel J. Goldstein, MD, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY, USA
The unique challenges of ECMO and MCS in COVID-19 therapy will be discussed.

Pandemic from the Front Lines
Luciano Potena, MD, PhD, Bologna Academic Hospital, Bologna, Italy
A presentation of the COVID-19 pandemic from the frontline perspective will include lessons learned during the pandemic. Further, the issues of lifting restrictions once a plateau or decline in cases is reached will be explored.

Donor Evaluation in CT Transplant
Christian Benden, MD, FCCP, Swisstransplant, Berne, Switzerland
Managing donors in an uncertain time with emerging testing options to balance risk to recipients and healthcare workers while maintaining transplant operations will be discussed.

Ethical Considerations for CT Transplant and VAD Programs in COVID-19
Are Martin Holm, MD, PhD, Oslo University Hospital, Oslo, Norway
Discuss how the resource allocation ethics associated with the COVID-19 pandemic intersect with the ongoing ethical challenges associated with the care of patients with end stage heart, lung and pulmonary vascular disease (including heart and lung transplant and mechanical circulatory support).
 

Continuing Education Information

Learning Objective – Explain how COVID-19 impacts the aspects of care surrounding your patients as it relates to current epidemiology, therapeutic options, critical care, support devices and donor management.

Target Audience – The target audience for this platform includes physicians, surgeons, scientists, pharmacists, nurses, transplant coordinators and other allied health and social science professionals engaged in the management and treatment of patients with advanced heart or lung disease, basic science or clinical research related to these fields, or other specialties which cause them to become involved in the treatment of patients with advanced heart or lung disease.

Activity Designed to Change – This activity is designed to change knowledge, competence and performance.

Learning Attributes   Patient Care and Medical Knowledge

Disclosures – Current guidelines state that participants in continuing medical and allied health professional education activities must be made aware of any affiliation or financial interest that may affect the program content or a speakers presentation. Planners, Faculty and Chairs participating in this meeting are required to disclose to the program audience any real or apparent conflict(s) of interest related to the content of their presentation or service as Chair/Planner. Disclosures will be distributed in the Learner Notification that you receive as a participant prior to the live virtual session. Additionally, all speakers have been asked to verbally disclose at the start of their presentation any financial interest or affiliations and to indicate if a product they are discussing is not labeled for the use under discussion or is still investigational.

Disclaimer – The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of the ISHLT.

Documenting CME Credits – The ISHLT provides CME certificates to those who have participated in an ISHLT educational activity. The ISHLT does not submit credits to regulating bodies or certifying organizations on behalf of the participants. It is the participants responsibility to submit proof of credits on his or her own behalf.
 

ACCME Accreditation

Physicians

Accreditation Statement - The International Society for Heart and Lung Transplantation (ISHLT) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement – ISHLT designates this live virtual activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses and Pharmacists

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and The International Society for Heart and Lung Transplantation (ISHLT). Amedco LLC is jointly accredited by the American Council for Continuing Medical Education (ACCME) the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation Statement – Amedco LLC designates this live virtual activity for a maximum of 1.5 contact hours for nurses and 1.5 knowledge-based contact hours for pharmacists. Learners should claim only the credit commensurate with the extent of their participation. Note to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request a certificate with 30 days of completion to meet submission deadlines.

Nurse Practitioners

The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education.

Transplant Coordinators Credit

An application has been submitted to the American Board for Transplant Certification for Continuing Education Points for this offering.